Clinical Trials
13
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)β’ Click on a phase to view related trials
VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
- Conditions
- Invasive Pulmonary AspergillosisInvasive Aspergillosis
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Vical
- Target Recruit Count
- 4
- Registration Number
- NCT03327727
- Locations
- πΊπΈ
University of Alabama at Birmingham Hospital, Division of Infectious Diseases, Birmingham, Alabama, United States
πΊπΈUC San Diego Moores Cancer Center, La Jolla, California, United States
πΊπΈUC Davis Health, Dept. of Internal Medicine, Div. of Infectious Diseases, Sacramento, California, United States
Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
- Conditions
- Herpes Genitalis
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Vical
- Target Recruit Count
- 261
- Registration Number
- NCT02837575
- Locations
- πΊπΈ
Alabama Vaccine Research Clinic at University of Alabama at Birmingham, Birmingham, Alabama, United States
πΊπΈMedical Center for Clinical Research, San Diego, California, United States
πΊπΈQPS Broward Research, Hollywood, Florida, United States
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
- Conditions
- Genital Herpes Simplex Type 2
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Vical
- Target Recruit Count
- 165
- Registration Number
- NCT02030301
- Locations
- πΊπΈ
Alabama Vaccine Research Clinic, Birmingham, Alabama, United States
πΊπΈBroward Research Group, Hollywood, Florida, United States
πΊπΈIndiana University Infectious Diseases Research, Indianapolis, Indiana, United States
Pandemic Influenza Plasmid DNA Vaccines (Needle)
- Conditions
- Influenza
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2009-02-12
- Lead Sponsor
- Vical
- Target Recruit Count
- 56
- Registration Number
- NCT00709800
- Locations
- πΊπΈ
Accelovance, San Diego, California, United States
πΊπΈSNBL, Baltimore, Maryland, United States
πΊπΈSUNY at Stonybrook, Stony Brook Medical Center, Stony Brook, New York, United States
Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)
- Conditions
- Influenza
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- Vical
- Target Recruit Count
- 47
- Registration Number
- NCT00694213
- Locations
- πΊπΈ
Accelovance, San Diego, California, United States
πΊπΈSNBL, Baltimore, Maryland, United States
πΊπΈSUNY at Stonybrook, Stony Brook Medical Center, Stony Brook, New York, United States
- Prev
- 1
- 2
- 3
- Next